CircUGGT2 is overexpressed in cisplatin-resistant gastric cancer cells and can bind competitively to miR-186-3p, lifting its inhibition of MAP3K9, which promotes the proliferation, invasion, and cisplatin resistance in gastric cancer cells (Chen X. Y. et al., 2024). The gene discussed is MAP3K9; the disease is gastric cancer.